From established players to up-and-coming firms, Canada’s pharmaceutical landscape is diverse and dynamic. Canadian drug companies are working to discover and develop major innovations...
The Trump administration continues its push to rebuild domestic supply chains for critical technologies through a US$1.4 billion public-private partnership with Vulcan Elements and...
Global gold producers reported robust third-quarter earnings on the back of record bullion prices. The yellow metal surged to its all-time high of US$4,379.13...
Sister Stephanie Schmidt had a hunch about what her fellow nuns would discuss over dinner at their Erie, Pennsylvania, monastery on Wednesday night. The...
Global gold producers reported robust third-quarter earnings on the back of record bullion prices. The yellow metal surged to its all-time high of US$4,379.13...
Quimbaya Gold Inc. (CSE: QIM,OTC:QIMGF) (OTCQB: QIMGF) (FSE: K05) (‘Quimbaya’ or the ‘Company’) is pleased to announce the closing of its previously announced ‘bought deal’ private placement,...
In this edition of StockCharts TV‘s The Final Bar, Dave answers viewer questions on using technical indicators on leveraged and inverse ETFs like SOXL and SOXS,...
In this edition of StockCharts TV‘s The Final Bar, Dave recaps a day where technology shares struggles, with leading names like NVDA and MU dropping bearish...
Editor’s Note: This article was originally published on November 21, 2022. This article has absolutely nothing to do with trend following or the markets....
Gilead Sciences’ (GILD) new HIV prevention shot, lenacapavir, hit it out of the park in a late-stage trial, showing 100% effectiveness. 2,000 women participated...